Impétigo, celulitis, ericipela & foliculitis en pacientes pediátricos
Palabras clave:
Impétigo, celulitis, erisipela, foliculitis, tratamiento del impétigo, agentes etiológicos de la erisipela, ecografía en celulitis, factores de riesgo de la foliculitisResumen
Las infecciones de piel y partes blandas son comunes en pediatría, principalmente causadas por alteraciones de la barrera cutánea que permiten la entrada de microorganismos como Staphylococcus aureus y Streptococcus pyogenes. Aunque hay escasa información epidemiológica local, estos patógenos están presentes en la piel y fosas nasales. Este estudio descriptivo se basó en una revisión bibliográfica de artículos recientes de revistas científicas reconocidas. Los hallazgos muestran que, aunque las infecciones cutáneas en niños son un motivo frecuente de consulta, su diagnóstico es un desafío, y a menudo se confunden con traumas, llevando a tratamientos tardíos y posibles complicaciones. Se recomienda el uso de ecografías y exámenes de laboratorio para mejorar la precisión diagnóstica.
Palabras claves: Impétigo, celulitis, erisipela, foliculitis, tratamiento del impétigo, agentes etiológicos de la erisipela, ecografía en celulitis, factores de riesgo de la foliculitis.
Abstract
Skin and soft tissue infections are common in pediatrics, mainly caused by disruptions in the skin barrier that allow the entry of microorganisms such as Staphylococcus aureus and Streptococcus pyogenes. Although there is limited local epidemiological information, these pathogens are present on the skin and nasal passages. This descriptive study was based on a literature review of recent articles from recognized scientific journals. The findings show that while skin infections in children are a frequent reason for consultation, their diagnosis is challenging and they are often confused with traumas, leading to delayed treatments and potential complications. The use of ultrasounds and laboratory tests is recommended to improve diagnostic accuracy.
Keywords: Impetigo, cellulitis, erysipelas, folliculitis, treatment of impetigo, etiological agents of erysipelas, ultrasound in cellulitis, risk factors for folliculitis.
Información del manuscrito:
Fecha de recepción: 06 de junio de 2023.
Fecha de aceptación: 12 de septiembre de 2023.
Fecha de publicación: 02 de octubre de 2023.
Descargas
Citas
Asmae, L., & Zakia, D. (2017). Child Erysipelas: About 16 Pediatric Cases. IJPA. (Nota: La cita es incompleta, por favor proporciona más detalles para una correcta conversión).
Atmis, B., Cevizli, D., Cagli, C., Saribas, E., Karakulak, V., Ozcan, D., ... & others. (2023). Nephrotic syndrome, skin involvement, and chronic lung disease: Answers. Pediatric Nephrology, 38(5), 1481-1483.
Barbieri E, Porcu G, Dona’ D, Falsetto N, Biava M, Scamarcia A, ... & et al. (2022). Non-bullous Impetigo: Incidence, Prevalence, and Treatment in the Pediatric Primary Care Setting in Italy. Frontiers in Pediatrics, 10, 753694.
Brindle R, Williams O, Barton E, & Featherstone P. (2019). Assessment of Antibiotic Treatment of Cellulitis and Erysipelas: A Systematic Review and Meta-analysis. JAMA Dermatology, 155(9), 1033.
Brindle, R., O’Neill, L., & Williams, O. (2020). Risk, Prevention, Diagnosis, and Management of Cellulitis and Erysipelas. Current Dermatology Reports, 9(1), 73-82.
Cannon J, Dyer J, Carapetis J, & Manning L. (2018). Epidemiology and risk factors for recurrent severe lower limb cellulitis: a longitudinal cohort study. Clinical Microbiology and Infection, 24(10), 1084-1088.
Chamli A, Zaouak A, & Hammami H. (2021). Genital Bullous Impetigo in a Child. Indian Pediatrics, 58(11), 1104.
D’Cunha N, Peterson G, Baby K, & Thomas J. (2018). Impetigo: A need for new therapies in a world of increasing antimicrobial resistance. Journal of Clinical Pharmacy and Therapeutics, 43(1), 150-153.
Department of Paediatrics and Adolescent Medicine, The University of Hong Kong, Pokfulam, Hong Kong, Leung T, Hon K, & Leung A. (2018). Group A Streptococcus disease in Hong Kong children: an overview. Hong Kong Medical Journal. http://www.hkmj.org/abstracts/v24n6/593.htm
Díez-Madueño K, Buendía Castaño D, Alonso-García S, & De La Cueva Dobao P. (2022). Foliculitis perforante. Medicina Clínica, 159(9), 456.
Frølunde A, Olesen A, Riber‐Hansen R, & Pallesen K. (2021). Eosinophilic pustular folliculitis of infancy: A rare diagnosis in children. Clinical Case Reports. https://onlinelibrary.wiley.com/doi/10.1002/ccr3.4167
Galli L, Venturini E, Bassi A, Gattinara G, Chiappini E, Defilippi C, ... & et al. (2019). Common Community-acquired Bacterial Skin and Soft-tissue Infections in Children: an Intersociety Consensus on Impetigo, Abscess, and Cellulitis Treatment. Clinical Therapeutics, 41(3), 532-551.e17.
Hatlen, T., & Miller, L. (2021). Staphylococcal skin and soft tissue infections. Infectious Disease Clinics of North America, 35(1), 81-105.
Henning M, Jemec G, & Saunte D. (2020). [Malassezia folliculitis]. Ugeskrift for Laeger, 182(47).
Johnson M. (2020). Impetigo. Advanced Emergency Nursing Journal, 42(4), 262-269.
Klotz C, Courjon J, Michelangeli C, Demonchy E, Ruimy R, & Roger PM. (2019). Adherence to antibiotic guidelines for erysipelas or cellulitis is associated with a favorable outcome. European Journal of Clinical Microbiology & Infectious Diseases, 38(4), 703-709.
Lin, H., Lin, P., Tsai, Y., Wang, S., & Chi, C. (2021). Interventions for bacterial folliculitis and boils (furuncles and carbuncles). Cochrane Database of Systematic Reviews, 2021(3). http://doi.wiley.com/10.1002/14651858.CD013099.pub2
Loadsman, M., Verheij, T., & Van Der Velden, A. (2019). Impetigo incidence and treatment: a retrospective study of Dutch routine primary care data. Family Practice, 36(4), 410-416.
Mannschreck, D., Feig, J., Selph, J., & Cohen, B. (2020). Disseminated bullous impetigo and atopic dermatitis: Case series and literature review. Pediatric Dermatology, 37(1), 103-108.
May, P., Tong, S., Steer, A., Currie, B., Andrews, R., Carapetis, J., ... & others. (2019). Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review. Tropical Medicine & International Health, 24(3), 280-293.
Ortiz-Lazo E, Arriagada-Egnen C, Poehls C, & Concha-Rogazy M. (2019). Actualización en el abordaje y manejo de celulitis. Actas Dermo-Sifiliográficas, 110(2), 124-130.
Pereira-Franchi, E., Barreira, M., Costa, N., Fortaleza, C., & Cunha, M. (2017). Prevalence of and risk factors associated with the presence of Staphylococcus aureus in the chronic wounds of patients treated in primary health care settings in Brazil. Revista da Sociedade Brasileira de Medicina Tropical, 50(6), 833-838.
Pérez-De La O AD, & García Romero M. (2017). Impétigo ampolloso. Acta Pediátrica de México, 38(5), 351.
Preda-Naumescu A, Elewski B, & Mayo TT. (2021). Common Cutaneous Infections. Medical Clinics of North America, 105(4), 783-797.
Prindaville, B., Belazarian, L., Levin, N., & Wiss, K. (2018). Pityrosporum folliculitis: A retrospective review of 110 cases. Journal of the American Academy of Dermatology, 78(3), 511-514.
Rambhia, P., Conic, R., Murad, A., Atanaskova-Mesinkovska, N., Piliang, M., & Bergfeld, W. (2019). Updates in therapeutics for folliculitis decalvans: A systematic review with evidence-based analysis. Journal of the American Academy of Dermatology, 80(3), 794-801.e1.
Reich, K., Kabashima, K., Peris, K., Silverberg, J., Eichenfield, L., Bieber, T., ... & others. (2020). Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatology, 156(12), 1333.
Robinson S, Jefferson I, Agidi A, Moy L, & Lake E. (2020). Pediatric dermatology emergencies. Cutis, 105(3), 132-136.
Romero C, Palma G, Larrea J, & Acuña K. (2019). Celulitis infecciosa: Incidencia, agentes patógenos más frecuentes y tratamiento. RECIAMUC, 2(1), 1121-1130.
Rosen, T., Albareda, N., Rosenberg, N., Alonso, F., Roth, S., Zsolt, I., ... & others. (2018). Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial. JAMA Dermatology, 154(7), 806.
Rrapi, R., Chand, S., & Kroshinsky, D. (2021). Cellulitis. Medical Clinics of North America, 105(4), 723-735.
Saadani, C. (2019). Erysipelas of the child: About 30 cases. Clinical Microbiology & Infectious Diseases, 4(2). https://www.oatext.com/erysipelas-of-the-child-about-30-cases.php
Salazar-Ospina, L., & Jiménez, J. (2018). High frequency of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in children under 1 year old with skin and soft tissue infections. Jornal de Pediatria, 94(4), 380-389.
Salleo E, MacKay C, Cannon J, & King B. (2021). Cellulitis in children: a retrospective single centre study from Australia. BMJ Paediatrics Open, 5(1), e001130.
Shriner A, & Wilkie L. (2017). Pediatric Cellulitis: A Red-Hot Concern. Pediatric Annals. https://journals.healio.com/doi/10.3928/19382359-20170620-01
Stevens D, & Bryant A. (2022). Streptococcus pyogenes Impetigo, Erysipelas, and Cellulitis. En J.J. Ferretti, D.L. Stevens, & V.A. Fischetti (Eds.), Streptococcus pyogenes: Basic Biology to Clinical Manifestations (2da ed.). University of Oklahoma Health Sciences Center. http://www.ncbi.nlm.nih.gov/books/NBK587091/
Suzuki C, Hase M, Shimoyama H, & Sei Y. (2016). Treatment Outcomes for Malassezia Folliculitis in the Dermatology Department of a University Hospital in Japan. Medical Mycology Journal, 57(3), 63-66.
Taiaroa G, Matalavea B, Tafuna’i M, Lacey J, Price D, Isaia L, ... & et al. (2021). Scabies and impetigo in Samoa: A school-based clinical and molecular epidemiological study. The Lancet Regional Health - Western Pacific, 6, 100081.
Titou H, Ebongo C, Bouati E, & Boui M. (2017). Risk factors associated with local complications of erysipelas: a retrospective study of 152 cases. Pan African Medical Journal. http://www.panafrican-med-journal.com/content/article/26/66/full/
Torrelo, A., Grimalt, R., Masramon, X., Albareda López, N., & Zsolt, I. (2020). Ozenoxacin, a new effective and safe topical treatment for impetigo in children and adolescents. Dermatology, 236(3), 199-207.
VanRavenstein K, Durham C, Williams T, & Smith W. (2017). Diagnosis and management of impetigo. The Nurse Practitioner, 42(3), 40-44.
Veraldi S, Desimine C, & Grancini A. (2019). Can folliculitis be caused by Staphylococcus epidermidis? Giornale Italiano di Dermatologia e Venereologia. https://www.minervamedica.it/index2.php?show=R23Y2019N02A0212
Webb E, Neeman T, Bowden F, Gaida J, Mumford V, & Bissett B. (2020). Compression Therapy to Prevent Recurrent Cellulitis of the Leg. New England Journal of Medicine, 383(7), 630-639.
Wen S, Lee L Yang, Daley A, Chow C, Phillips R, & Gwee A. (2018). Persistent Folliculitis in An Immunocompetent Child: Letters to the Editor. Journal of Paediatrics and Child Health, 54(11), 1281-1282.
Williamson D, Carter G, & Howden B. (2017). Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns. Clinical Microbiology Reviews, 30(3), 827-860.
Yang Y, Huang W, Zhong W, Fu Y, He P, Zhao G, ... & et al. (2018). Bilateral Lower Limb and Abdominal Elephantiasis Due to Erysipelas. Chinese Medical Journal (English Edition), 131(7), 873-874.
Yueh, C., Chi, H., Chiu, N., Huang, F., Tsung-Ning Huang, D., Chang, L., ... & others. (2022). Etiology, clinical features, management, and outcomes of skin and soft tissue infections in hospitalized children: A 10-year review. Journal of Microbiology, Immunology, and Infection, 55(4), 728-739.
Publicado
Cómo citar
Número
Sección
Derechos de autor 2023 Revista Científica Arbitrada en Investigaciones de la Salud GESTAR. ISSN: 2737-6273.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
